PAC-113 an anti-fungal, for the treatment of oral candidiasis infections. It is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in saliva.
PAC-113 is a synthetic peptide compound designed to mimic the activity of naturally occurring antimicrobial peptides. Structurally, it is derived from histatin 5, a salivary peptide known for its potent antifungal properties, and has been engineered to enhance its stability and functional activity. As a cationic peptide, PAC-113 exhibits amphipathic characteristics, enabling it to interact with microbial membranes and disrupt their integrity. Its relevance in biochemical research stems from its unique mechanism of action, which targets microbial cell membranes rather than traditional metabolic pathways, making it an important tool for studying peptide-membrane interactions, antimicrobial resistance, and peptide-based therapeutic strategies in preclinical settings.
Antimicrobial mechanism studies: PAC-113 is widely used in research focused on elucidating the mechanisms by which cationic peptides disrupt microbial membranes. Its well-characterized structure and activity profile provide a model system for investigating the biophysical interactions between peptides and lipid bilayers. Researchers utilize PAC-113 to examine peptide-induced membrane permeabilization, pore formation, and the role of charge and hydrophobicity in antimicrobial efficacy. Insights gained from these studies contribute to the broader understanding of innate immune defenses and the design of novel antimicrobial agents.
Antifungal activity assays: The peptide is frequently employed in in vitro assays to evaluate antifungal efficacy, particularly against Candida species and other clinically relevant fungi. Its origin from histatin 5, a peptide with established antifungal activity, makes PAC-113 an effective positive control or reference compound in comparative studies. By analyzing its activity under various conditions, researchers can assess the impact of peptide modifications, environmental factors, and microbial resistance mechanisms on antifungal potency.
Peptide structure-activity relationship (SAR) investigations: PAC-113 serves as a valuable model for structure-activity relationship studies within the field of antimicrobial peptides. Its sequence modifications relative to native histatin 5 allow researchers to systematically explore how specific amino acid substitutions influence antimicrobial spectrum, potency, and selectivity. These SAR studies inform the rational design of next-generation peptides with improved stability, reduced toxicity, or enhanced activity against resistant strains, supporting the advancement of peptide-based antimicrobial strategies.
Biofilm disruption research: The compound is utilized in experimental models to assess its efficacy in disrupting microbial biofilms, which are complex communities of microorganisms that exhibit increased resistance to conventional antimicrobials. PAC-113's ability to penetrate and destabilize biofilm matrices is investigated in both single-species and mixed-species biofilm systems. Such studies are crucial for identifying peptide candidates capable of overcoming biofilm-associated resistance, a significant challenge in both medical device and industrial contexts.
Peptide formulation and delivery studies: PAC-113 is also incorporated into research focused on developing effective peptide delivery systems for antimicrobial applications. Its physicochemical properties and robust activity serve as benchmarks in evaluating encapsulation techniques, stability in various matrices, and controlled-release formulations. These studies facilitate the optimization of peptide delivery vehicles, such as hydrogels, nanoparticles, or coatings, which are essential for maximizing the practical utility of antimicrobial peptides in laboratory and industrial environments.
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More